The market performance of Oncternal Therapeutics Inc’s stock has been turbulent in recent times. Over the last year, the company’s stock reached its highest point at $13.14 on 12/22/23, while the lowest value for the same duration was $1.03 on 11/25/24.
52-week price history of ONCT Stock
A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Oncternal Therapeutics Inc’s current trading price is -94.60% away from its 52-week high, while its distance from the 52-week low is -31.07%. The stock’s price range during this period has spanned from $1.03 to $13.14. In the Healthcare sector, the Oncternal Therapeutics Inc’s shares surpassed a trading volume of approximately 0.79 million for the day, which was noticeably higher compared to the average daily volume of 9.96670.0 over the past three months.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Market Capitalization and Financial Performance: An In-Depth Look
Oncternal Therapeutics Inc (ONCT) has experienced a quarterly decline of -83.75% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 2.06M and boasts a workforce of 27 employees.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 3.3366, with a change in price of -6.4400. Similarly, Oncternal Therapeutics Inc recorded 73,837 in trading volume during the last 100 days, posting a change of -90.07%.
Examining ONCT’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for ONCT stands at 0.02. Similarly, the long-term debt-to-equity ratio is also 0.00.
ONCT Stock Stochastic Average
Today, Oncternal Therapeutics Inc’s raw stochastic average for the past 50 days stands at 5.14%, indicating a decline from the raw stochastic average of the last 20 days, which was 7.83%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 13.42% and 14.05% respectively.
ONCT Stock Price Performance Analysis
The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. The index has shown a price loss of -93.38% this year. Over the last six months, there has been a stronger performance of -92.45%. The price of ONCT leaped by -52.35% during the last 30 days period. For the last 5-days stocks have slided -33.64%.
